Howard University Hospital
Howard University Hospital
Washington D.C., District of Columbia, United States4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer | breast adenocarcinoma | Active, not recruiting | Phase 3 | 2026-10-01 | NCT00433511 | |
| BRAVE Program to Improve Safety and Reduce Violence Risk in Early Psychosis | Psychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder | Recruiting | Not applicable | 2026-07-29 | NCT07417904 | |
| Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer | Disease Attributes, Genetic Risk Score, Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Polygenic Risk Score, Urogenital Diseases, Urogenital Neoplasms, disease susceptibility, inherited disease susceptibility, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Not applicable | 2025-11-10 | NCT06398639 | |
| Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Recruiting | Phase 3 | 2024-10-22 | NCT02901184 |